Additional file 7 of Contrasting molecular and pharmacodynamic signatures of response and resistance to sequential bortezomib and temozolomide in recurrent IDH-wildtype glioblastoma and grade 4 IDH-mutant astrocytoma: an exploratory interim analysis

Authors

Institutions

Publication Details

Journal
Figshare
Published
2026-10-27
DOI
https://doi.org/10.6084/m9.figshare.34823065
Primary Topic
Glioma Diagnosis and Treatment
Type
article
Field-Weighted Citation Impact
0.00
Controls
|||
ALL TIME
JAN
FEB
MAR
APR
MAY
JUN
JUL
AUG
SEP
OCT
article

Additional file 7 of Contrasting molecular and pharmacodynamic signatures of response and resistance to sequential bortezomib and temozolomide in recurrent IDH-wildtype glioblastoma and grade 4 IDH-mutant astrocytoma: an exploratory interim analysis

Jorunn Brekke, Leif Oltedal, Stein Atle Lie, Mohummad Aminur Rahman et al.
Figshare
Glioma Diagnosis and Treatment
article

Additional file 7 of Contrasting molecular and pharmacodynamic signatures of response and resistance to sequential bortezomib and temozolomide in recurrent IDH-wildtype glioblastoma and grade 4 IDH-mutant astrocytoma: an exploratory interim analysis

Jorunn Brekke, Leif Oltedal, Stein Atle Lie, Mohummad Aminur Rahman, Frode Selheim, Dorota Goplen, Judit Haász, Martha Chekenya, Andreas Waha, Even Birkeland, Surendra Kumar
article en

Abstract

No abstract available for this paper.
Figshare
University of Bonn (DE), Haukeland University Hospital (NO), University of Bergen (NO)
Openalex Percentile: Top 12%
Glioma Diagnosis and Treatment
AI Navigator

Ask Laika to Summarize, Analyze, and Connect papers live on the map.

Summarize Papers & Methodologies

Extract key findings, datasets, and comparative methods across publications.

Benchmark Rankings & Visual Analytics

Rank top research institutions, authors, funders, topics, and journals by Field-Weighted Citation Impact (FWCI) and paper volume with instant charts.

Connect Distant Disciplines

Bridge topological clusters on the map to find hidden collaborative intersections.

Laika access coming soon